Invea Therapeutics Company Profile, Contacts & Intelligence

Biotechnology2614 Boston Post Rd12 employeesFounded 2021
3 contacts with email or phone data3 with email data1 with phone data
Employees
12
Company source estimate
Reachable Contacts
3
Visible contacts with email or phone data
Contacts With Email
3
3 of 4 visible contacts

Invea Therapeutics Overview

Overview We are a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs. Our aim is to develop oral, safe and effective small-molecule therapies that control inflammation, prevent tissue damage, improve quality of life and achieve long-term disease remission. We believe that the lack of an in-depth understanding of the pathophysiological mechanisms underlying immune-mediated inflammation has restricted therapeutic options for several IMIDs to merely symptomatic interventions, with limited effectiveness. Our drug discovery and development approach combines artificial intelligence, or AI, and machine learning, or ML, with our team’s extensive experience and expertise, to decode the mechanisms and pathways that drive the initiation and progression of inflammation for patients with IMIDs. We currently have two product candidates, INVA8001, which we plan to progress into Phase 2b of clinical development, and INVA8003, which is in the early stage preclinical development. We believe that our product candidates, INVA8001 and INVA8003, if approved, can potentially transform the treatment of several IMIDs, such as atopic dermatitis, or AD, and chronic urticaria, or CU, which are characterized by limited or no available therapeutic options or patient populations that are unresponsive, partially responsive or develop resistance to currently available therapies. INVA8001 is designed as an oral, small molecule, highly selective and potent inhibitor of chymase, a key mediator of mast cells driving inflammation, epithelial barrier damage and fibrosis.

Headquarters
2614 Boston Post Rd
Industry
Biotechnology
Founded
2021

Invea Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

3 contacts with contact data
3 with email data and 1 with phone data in the visible sample.

Invea Therapeutics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Invea Therapeutics Workforce Composition

Seniority breakdown across 3 visible profiles.

Executive
2
Individual contributor
1

Compare Similar Companies to Invea Therapeutics

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Biohaven Biotechnology Research 441 View company
Global Antibiotic R&D Partnership (GARDP) Research Services 102 View company
BioXcel Therapeutics, Inc. Biotechnology 65 View company
BioXcel, LLC Biotechnology Research 48 View company
Nabriva Therapeutics plc Biotechnology Research 28 View company
AlphaMeld Corporation Information Technology & Services 25 View company
VedTechBio Biotechnology Research 14 View company
Asklepion Pharmaceuticals LLC Biotechnology Research 13 View company
Neurocentrx Pharma Ltd. Biotechnology 6 View company
RenaissThera Biotechnology Research 2 View company